CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324577
- Phone
- 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market sale Chief Legal Compliance Officer sold 1,844 shares at $28.05 ($51,724)
- 4 Open-market sale VP, Prin. Accounting Officer sold 1,144 shares at $28.05 ($32,089)
- 4 Open-market sale Chief Executive Officer sold 11,087 shares at an average $27.55 ($305,490)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Regulation FD disclosure · Other events
- 4/A Grant or award Director acquired 18,400 shares (grant or award)
- 4/A Grant or award Director acquired 18,900 shares (grant or award)
- SCHEDULE 13D Stake Beneficial Ownership Report
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market sale Chief Legal Compliance Officer sold 8,829 shares at an average $30.09 ($265,628)
- 4 Open-market sale VP, Prin. Accounting Officer sold 5,628 shares at an average $30.09 ($169,324)
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale Chief Executive Officer sold 58,258 shares at an average $27.58 ($1,606,562)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 1 of 28 · 553 filings